Amsterdam, 10 July 2023 – Investment company Holland Capital is investing in Chainresult and Supply Chain Company, two renowned players in the digitalization of the food & agri value chain. The investment by Holland Capital enables the organizations to realize their international growth ambitions.

Supply chain management systems

The success of food & agri companies is increasingly determined by their control over the value chain. Improved efficiency and risk management play a significant role in this regard.

The food & agri market is rapidly evolving in terms of digitalizing its value chain. The unique characteristics of the food & agri market require a specialized approach by technology partners who understand the sector’s needs, processes, and complexities.

Combined solution

The key to successful digitalization lies in combining software implementation with good business implementation. Chainresult and Supply Chain Company provide both components, with in-depth knowledge of the food & agri market and an impressive track record with internationally leading companies. Together, they are well positioned to guide the further digitalization of the chain.

Chainresult and Supply Chain Company operate with approximately 50 employees from offices in Oosterbeek, Arnhem, Copenhagen (DK), and Auckland (NZ)

Jan Willem Rijkse, CEO of Chainresult: “Our ambition is high and reflects that of our partners. Together, we want to continue growing in the coming years and, with additional strength and scale, execute more and larger projects for our clients.”

Henk Jan Rijkse, CEO of Supply Chain Company: “To continue serving our partners optimally, we want to keep growing and continuously expand the range of digitalization solutions. In Holland Capital, we have found a valuable partner who, with its experience in building software implementation companies and making add-on acquisitions, can actively contribute to realizing our ambitions, both from our current offices and in Germany and the United Kingdom.”

Hubert Verbeek, Managing Partner at Holland Capital: “Based on our experiences in the technology and healthcare sectors, we see significant opportunities in the food & agri sector. Technology plays an increasingly important role to sustainably and optimally feed the world. Additionally, nutrition plays an increasingly important role in disease prevention and maintaining a healthy lifestyle. Since the beginning of this year, we have been actively focusing on the food & agri market. We are delighted with the investment in Chainresult and Supply Chain Company and look forward to supporting the company, together with management, in its growth ambition.”

About Chainresult

Chainresult was founded in 2002 and specializes in Business Implementation, with a focus on preparing organizations, business processes, and master data for a successful implementation and adoption of business systems, including ERP and other supply chain applications.

Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path.

Palliative terminal care

The aging population in the Netherlands and the increasing number of elderly living at home have led to a higher demand for palliative terminal care at home. Attenza provides this care to patients who wish to spend their last days at home with an intensive need for care. Attenza is able to quickly scale up or down palliative terminal care requests and is up to 24 hours per day available at the patient with a small team of care takers to provide comfort and quality care during the final stage of life. The company uses a proprietary software application, which contributes to the success and self-organization of the team, the quality of care and rapid deployment.

The partnership

Due to the partnership with Holland Capital Attenza can further expand its care services, resulting in nationwide coverage.

Carin van der Kaaden (Director of Attenza): “We are delighted to continue our passion together with Holland Capital. Enabling the highest possible quality of both living and dying at home with a small team of dedicated and well-trained professionals, for patients who have the last wish to pass away at home.”

Margot Engels (Partner Healthcare of Holland Capital): “We are proud to add Attenza to our portfolio of healthcare companies. We look forward to supporting the organization and its management in their growth ambitions.”

Almende has been involved in Attenza as a shareholder since 2017 and has actively supported the establishment and expansion of its proposition.

Jan Peter Larsen, CEO of Almende: “We are proud of the unique concept we have established with Attenza and the impact it has on people’s lives. The arrival of Holland Capital is the next step in Attenza’s ambition to offer this form of care nationwide.”

About Attenza

Attenza, founded in 2015, provides palliative terminal intensive care for individuals with specialized needs. Attenza’s mission is to ensure that everyone can spend their last weeks of their life comfortably at home. This is made possible through the swift and effective deployment of a small team of expert caregivers per patient.

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 160 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare, Technology and Food & Agri. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

About Almende

Almende is a Rotterdam-based venture builder that focuses on self-organization and technological innovation with a significant societal impact. With over 20 years of experience, Almende has created and scaled successful startups and scaleups in the fields of robotics, communication, and healthcare.

Amsterdam/Utrecht, 4 April 2023 – Holland Capital sells its stake in Valori to Cerios.

Valori believes that embedding integral quality into IT systems is crucial to allow carefree innovation. The Quality Assurance and Test Consultants of Valori build towards the quality of IT systems in all stages of software development: Building IT Quality. Valori has been doing this for over 33 years with Quality Assurance advisory, expert services and proprietary technology solutions. The eventual goal is to bring software faster into production with better and more sustainable quality.

Growth through buy and build

Holland Capital has been an active shareholder of Valori since 2019. Over the last 4 years, they have supported the team of Jaap Merkus vigorously to improve the strategic positioning of the business and to further professionalise the organisation. The buy and build strategy of Valori led to 2 takeovers. As a result, Valori could offer its clients a uniquely integrated quality solution.

Ewout Prins, managing partner at Holland Capital: “We’re very proud that we had the opportunity to embark on this journey with Valori over the past 4 years where we could help realise their growth ambitions. The acquisition by Cerios will allow Valori to enter into a new chapter of its development.”

Jaap Merkus, CEO Valori: “Valori managed to realise a unique acceleration in achieving its ambitions thanks to the close collaboration with Holland Capital. Targeted acquisitions and solid entrepreneurship were at the centre of that. That is why we are ready for the next chapter where we will join Cerios, supported by Avedon. In collaboration with Cerios we will be able to realise the next stage of growth for our clients.”

Next stage of growth for Cerios

The new brand Cerios will bring together the flagship businesses Salves, De Agile Testers Quality Accelerators and Valori into one ‘House of Brands’. This will allow them to gain a leading position in the consolidating market of quality and software testing. Through this collaboration the companies create more opportunities for consultants and a broader offering for their clients while maintaining their proper identity and autonomy.

About Holland Capital

Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of healthcare, technology and food & agri. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs.

Sirius Pintuition^® – Moving from Localization to Surgical Marker Navigation

Eindhoven, Netherlands – 28 March 2023 – Our portfolio company Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The funding will accelerate the worldwide growth of their product Pintuition and support further product development. Holland Capital acted as lead investor for this series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, and a major investment from Sirius Medical’s management and team. Norgine Ventures joined as a new investor in this round to support further commercial roll-out.

Sirius’ state-of-the-art navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and more than 5,000 successful Pintuition procedures across Western Europe and the US, the company experienced an unprecedented growth in revenue in 2022, attributable to Pintuition’s ease of use, straightforward implementation, and its unmatched precision in locating the target tissue.

“Sirius Medical has done a great job developing and bringing to market the Pintuition technology with a strong commercial start”, says Peter Stein, Chief Executive of Norgine Ventures. “Norgine Ventures is excited to support Sirius Medical’s leadership and their vision to deliver cost effective solutions in surgery.”

“We are excited about the market potential for surgical marker navigation,” says Jan Frens van Giessel, partner at Holland Capital. “We believe that the Pintuition technology and its future innovations will significantly improve surgery of non-palpable tumors for patients, physicians and improve the care for cancer patients.”

“Having become the fastest growing company in the industry is a clear confirmation of the unique benefits that our technology brings to both patients and physicians,” says Bram Schermers, CEO at Sirius Medical.  “Supported by this latest funding round I am confident that our highly talented and motivated team will further drive the adoption of Pintuition across the globe.”

About Sirius Medical

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared.  Sirius Medical is rapidly expanding with over 100 centers and an international sales network in Europe and the USA. www.sirius-medical.com 

About Holland Capital

Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

Sirius Pintuition^® – Moving from Localization to Surgical Marker Navigation

28 March 2023 – Eindhoven, Netherlands – Our portfolio company Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The funding will accelerate the worldwide growth of their product Pintuition and support further product development. Holland Capital acted as lead investor for this series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, and a major investment from Sirius Medical’s management and team. Norgine Ventures joined as a new investor in this round to support further commercial roll-out.

Sirius’ state-of-the-art navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and more than 5,000 successful Pintuition procedures across Western Europe and the US, the company experienced an unprecedented growth in revenue in 2022, attributable to Pintuition’s ease of use, straightforward implementation, and its unmatched precision in locating the target tissue.

“Sirius Medical has done a great job developing and bringing to market the Pintuition technology with a strong commercial start”, says Peter Stein, Chief Executive of Norgine Ventures. “Norgine Ventures is excited to support Sirius Medical’s leadership and their vision to deliver cost effective solutions in surgery.”

“We are excited about the market potential for surgical marker navigation,” says Jan Frens van Giessel, partner at Holland Capital. “We believe that the Pintuition technology and its future innovations will significantly improve surgery of non-palpable tumors for patients, physicians and improve the care for cancer patients.” 

“Having become the fastest growing company in the industry is a clear confirmation of the unique benefits that our technology brings to both patients and physicians,” says Bram Schermers, CEO at Sirius Medical.  “Supported by this latest funding round I am confident that our highly talented and motivated team will further drive the adoption of Pintuition across the globe.”

About Sirius Medical

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared.  Sirius Medical is rapidly expanding with over 100 centers and an international sales network in Europe and the USA. www.sirius-medical.com

About Holland Capital

Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

Amsterdam, 14 March 2023 – Our portfolio company YOEP will collaborate with De Praktische GGZ. The combination, made possible by Holland Capital, will further create an organisation with a wide range of both youth assistance and mental healthcare.

De Praktische GGZ offers outpatient mental healthcare to children, young people and adults with a professional team of psychologists and coordinating practitioners.

Wide range of integrated youth care and mental health care

By joining forces YOEP expands its activities and specialisation into adult mental healthcare. For clients it creates an organisation with a broad offering of integrated (youth) assistance and mental healthcare. The collaboration will contribute to more effective and affordable (youth) care.

Growth ambitions YOEP

Partnering with De Praktische GGZ is part of YOEP’s growth ambitions. After the acquisition of Ad Astra in March 2022, this is the second step in the company’s growth strategy. The collaboration further contributes to more effective and affordable (youth) care for clients, municipalities and insurers. In addition, the collaboration offers opportunities for further training and development of the employees.

Marije Veen, Director of YOEP: “Thanks to the acquisition of De Praktische GGZ we can, among others, work on strengthening the cooperation between adult mental health care and youth care. Close cooperation between these two is essential in order to be able to provide good care to families.”

Inge Lobbes-Dijkgraaf, director of De Praktische GGZ, “The care for our employees is just as important to us as the care for our clients. The merger creates an even greater foundation for innovation and continuous improvement processes for both the employees of De Praktische GGZ and those of YOEP”.

About De Praktische GGZ

De Praktische GGZ originated from the Practical Youth Care Zoetermeer, which was founded in 2012 and managed by Inge Lobbes-Dijkgraaf and Paul Obdam. The organisation provides outpatient mental healthcare to children, young people and adults. De Praktische GGZ has more than 80 employees and is active in the regions of Haaglanden, Midden-Holland, Holland-Rijnland, Utrecht-West and Rivierenland.

About YOEP

YOEP was founded by Michiel Noordzij, a child-and youth psychiatrist, and Simon van den Brekel in 2015. The organisation provides outpatient specialised healthcare (SGGZ) to children and young adults until the age of 23. The care is provided by more than 180 employees using a self-developed e-health application, the Functionering Profiel. Ad Astra, offering guidance and youth assistance, has been part of YOEP since March 2022. The organisation is active in the regions of Zuid-Holland, Midden-Holland, Haaglanden, Holland-Rijnland, greater Amsterdam and Gooi en Vechtstreek.

About Holland Capital

Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

Since 2021, Holland Capital has been the shareholder of YOEP and has supported the organization actively with both operational and strategic initiatives.

Do you want to step into the exciting world of Private Equity?

Holland Capital, an independent private equity firm with a focus on the Benelux & German mid-market, is looking for a full-time intern to join its buy-out team.
Within 5 months, you will familiarize yourself with all aspects of the investment process to ramp up all skills related to PE investing.

Do you want to step into the exciting world of Venture Capital?

Holland Capital is looking for a full-time intern to join our VC team. Within 5 months, you will familiarize yourself
with all aspects of the investment process to ramp up all skills related to VC investing.

Do you want to step into the exciting world of Private Equity?

Holland Capital is an independent private equity firm focusing on technology and healthcare companies in the Benelux and DACH regions. For our team in Düsseldorf, we are looking for interns who want to actively accompany the investment process and gain in-depth knowledge in the field of private equity.

Interns in the investment team work as a recognized team member with the investment professionals and familiarize with the comprehensive private equity business. We are looking for interns to support the team in Düsseldorf, starting immediately and on an ongoing basis.

Amsterdam, 9^th of January 2023 – After a period of thorough preparation and refinement, the moment has arrived: our new consortium for digital transformation services launches its name: Emixa, accompanied by a new website and corporate identity. With Emixa, our portfolio companies Appronto, cards PLM Solutions, Dimensys, Magnus Digital and OnePLM have joined forces to complement one another’s services and provide customers with innovative, high-quality, and full-service solutions in the field of digital transformation. Placing a special focus on the manufacturing industry, also known as ‘Industry 4.0’, using Siemens, SAP, Mendix and other leading technologies.

Emixa is the only specialist that can realize the combination of Siemens/Mendix/SAP technology solutions. For clients this offers a unique one-stop shop that delivers the integrated solutions for next level digital transformation. Every industry has its own dynamics, with its own issues and challenges. Focussing on specific industries enables us to closely follow the trends and developments and to provide extra added value to companies in those markets. It is our ambition to make the most impact for our clients, as we already have been doing for decades within the technology consultancy firms part of Emixa.

Growth through a buy-and-build strategy

With the financial support of investor Holland Capital, Emixa is able to follow a buy-and-build strategy that allows the consortium to expand its business and service portfolio. The five companies that are united in Emixa employ a total of 420 people and focus on issues related to process optimisation, product lifecycle and asset management, IT architecture, low-code applications, system integrations, data analytics and change management. Emixa has the ambition to become one of the leading players in Western Europe and expand its established presence in Belgium, the Netherlands and the United Kingdom to the DACH region.

The companies that form Emixa will remain active under their own names and strive to grow their services related to digital transformation. Each in its own way, the companies united in Emixa make a major contribution to organisations in various sectors, such as: manufacturing, (online) retail, logistics, construction, infrastructure, financial services and education.

“The world is changing at a rapid pace. To remain competitive, companies have to choose a business model and complementary IT architecture that allow them to lead the way. Due to the powerful and unique combination of industry knowledge and technology expertise in the field of ERP, low-code applications, integrations and PLM solutions, we enable our customers to win in the challenging era of full-scale digitisation”, says Emixa CEO Peter-Jan Simons.

The companies behind Emixa

Emixa is a consortium that combines the knowledge, expertise and specialities of several renowned companies.

Appronto

Appronto was founded in 2013 in the Dutch city of Breda. The company focuses on the development of digital solutions for complex issues. Appronto is a specialist in the development of low-code solutions on the Mendix platform and in the realisation of system integrations via Boomi’s cloud integration platform. In 2021, Appronto became the first European Siemens Smart Expert Partner, received the Boomi Partner Spotlight Award and was chosen as Siemens’ Top Cloud Partner in the Benelux area.

cards PLM Solutions

cards PLM Solutions was founded in 1999 and has locations in Best (NL) and Genk (B). With a team of 56 professionals, the organisation specialises in the digitisation of business processes and information flows within the manufacturing industry. Many of the company’s customers are active in industries such as automotive, aerospace, high-tech machine building, medical devices, and consumer goods. Over the years, the company has developed into a specialised product lifecycle management (PLM) solutions provider. cards is a Siemens Platinum Expert Partner for Siemens Digital Industries Software.

Dimensys

Dimensys was founded in the year 2000 and helps companies achieve operational excellence in their business processes. Dimensys makes the life cycle of assets and products transparent, predictable and repeatable. This allows organisations to use assets more effectively. The company uses years of experience in the knowledge domains of asset and product lifecycle management, project and portfolio management, and supply chain management. Dimensys is a certified SAP Gold Partner, SAP Partner Center of Expertise and SAP Recognized Expertise Partner.

Magnus Digital

Magnus, founded in 1990, was the first SAP partner and one of the first Mendix partners in the Netherlands. Magnus Digital is an innovative IT and organisational consultancy agency that works with leading clients. Its portfolio contains a wide range of digital services, from advice to realisation. With approximately 100 consultants, it provides services related to digital transformation, data analytics, ERP implementations, and the development of low-code solutions. It also unburdens customers of the management of these solutions. Magnus Digital is active in retail, FMCG, wholesale, manufacturing, education, transport, construction, and several other industries.

OnePLM

OnePLM is one of the world’s largest Siemens Digital Industries Software Partners and the number one European Partner. The company has more than 25 years of industry experience and employs a team of 107 people. OnePLM provides PLM services and solutions to manufacturing companies in the UK and Ireland, both independent users and OEMs. In addition, OnePLM provides training, consultancy and support to a wide range of software customers.

Holland Capital

Over the past 40 years, Holland Capital has successfully invested in more than 150 Dutch SMEs. Using a clear, socially responsible and sustainable investment strategy, the company is active in the attractive growth markets of healthcare and technology. Holland Capital’s investment team seeks to build an open, sustainable and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving sustainable growth.